Wikipedia -WSS

Wikipedia

author：hotspot 2025-09-27 19:50:17 - browse：392

Stock illustration of computer and medication — Adobe

Digital therapeutics company Click Therapeutics announced Wednesday it will acquire the assets of Better Therapeutics, developer of a software-based treatment for diabetes. Click, which did not disclose how much it is paying for the assets, hopes to adapt Better’s tech for use alongside GLP-1 medications.

Better Therapeutics announced in March that it was delisting from the Nasdaq stock exchange and shutting down operations as it sought strategic alternatives. The company had been, since last year, searching for ways to stay afloat as its cash reserves dwindled.

Last, year, Better received Food and Drug Administration clearance for AspyreRx, a prescription app that delivers cognitive behavioral therapy and had been shown to reduce A1c levels in people with type 2 diabetes. Still, the company has been unable to ramp up significant commercial traction. Better also had a pipeline of other products targeting cardiometabolic conditions, and had made early claims about the benefits of AspyreRx in people taking GLP-1s for diabetes management.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： How to use technology to prevent future drug shortages

Wikipedia

WSS

Rapinoe says her retirement call will help US women's soccer team to focus at World Cup

Methadone doses haven’t kept up in the age of fentanyl

Cuban government calls US nuclear submarine stop a 'provocative escalation'

One Duchenne patient's bittersweet hope for new treatment

Cuban government calls US nuclear submarine stop a 'provocative escalation'

After half a century, Israel moves to evict squatter from his cave home on the beach

knowledge

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

explore

23andMe had bad news about my health. I wish a person had delivered it

Anavex keeps shifting the goalposts in its clinical trials

Walensky prepares to leave CDC — and Congress — behind

Naloxone nonprofit donates 200,000 doses after FDA approval

After affirmative action ruling, medical educators look to 'holistic review'

Digital health funding stays low as a new reality sets in

BioMarin wins approval for gene therapy to treat hemophilia A

Giant panda gives birth to squirming, squealing healthy twin girls at South Korean theme park

Guidelines to prevent youth baseball injuries need more muscle

How are insurers handling Leqembi and related scans?

hotspot

Sickle cell gene therapy cures need to be accessible in Africa

A biotech analyst on neuroscience, placebo effect, not over

For Cytokinetics, FDA rejection of heart drug would help, not hinder

Iran's president begins a rare visit to Africa 'to promote economic diplomacy'

NIH trials fail to test meaningful long Covid therapies, experts say

A biotech analyst on neuroscience, placebo effect, not over

leisure time

explore

Wikipedia

hotspot